Jin Zhong
jzhong@sibs.ac.cn
English, Chinese
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 1997-08--2003-08 PhD: University of Texas
  • 1994-09--1997-07 Master's: Peking University
  • 1990-09--1994-07 Bachelor's: Sichuan University
  • 2016-01~Present - Chinese Academy of Sciences - Distinguished Researcher
  • 2013-01~Present - ShanghaiTech University - Distinguished Professor
  • 2007-01~Present - Shanghai Pasteur Institute, Chinese Academy of Sciences - Researcher, Group Leader, Assistant Director
  • 2003-09~2006-12 - Scripps Research Institute, USA - Postdoctoral Researcher, Research Assistant
  • 2015: 'Emergences' Award by the French Embassy in China
  • 2014: Excellent Graduate Student Supervisor Award by the Chinese Academy of Sciences
  • 2013: State Council Special Government Allowance Expert
  • 2012: Outstanding Young Scientific and Technological Innovation Talent Nomination Award by the Shanghai Branch of the Chinese Academy of Sciences
  • 2012: Zhu Li Yuehua Excellent Teacher Award by the Chinese Academy of Sciences
  • 2010: Outstanding Young Talent by the Chinese Academy of Sciences
  • 2009: French Talent Innovation Award
Virology
Immunology
Antiviral Drug Screening
  • Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent, Yifan Xing, Ran Chen, Feng Li, Bin Xu, Lin Han, Chaolun Liu, Yimin Tong, Yaming Jiu, Jin Zhong, GuoChun Zhou, 2023
  • Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance, Chaolun Liu, Mingzhe Guo, Lin Han, Jie Lu, Xiaogang Xiang, Qing Xie, Janin Nouhin, Veasna Duong, Yimin Tong, Jin Zhong, 2023
  • Identification of a novel replication-competent hepatitis C virus variant that confers the sofosbuvir resistance, Leumi, Steve, Guo, Mingzhe, Lu, Jie, Wang, Zhaoning, Gan, Tianyu, Han, Lin, Ngari, Jackline, Tong, Yimin, Xiang, Xiaogang, Xie, Qing, Wang, Lanfeng, Zhong, Jin, 2022
  • Inhibitor Development against p7 Channel in Hepatitis C Virus, Wei, Shukun, Hu, Xiaoyou, Du, Lingyu, Zhao, Linlin, Xue, Hongjuan, Liu, Chaolun, Chou, James J, Zhong, Jin, Tong, Yimin, Wang, Shuqing, OuYang, Bo, 2021
  • Photo-catalyzed TiO2 inactivates pathogenic viruses by attacking viral genome, Tong, Yimin, Shi, Gansheng, Hu, Gaowei, Hu, Xiaoyou, Han, Lin, Xie, Xiaofeng, Xu, Yongfen, Zhang, Rong, Sun, Jing, Zhong, Jin, 2021
  • Junctional and somatic hypermutation-induced CX4C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody, Yi, Chunyan, Xia, Jing, He, Lan, Ling, Zhiyang, Wang, Xuesong, Yan, Yu, Wang, Jiangjun, Zhao, Xinhao, Fan, Weiguo, Sun, Xiaoyu, Zhang, Ronghua, Ye, Sheng, Zhang, Rongguang, Xu, Yongfen, Ma, Liyan, Zhang, Yaguang, Zhou, Honglin, Huang, Zhong, Niu, Junqi, Long, Gang, Lu, Junxia, Zhong, Jin, Sun, Bing, 2021
  • TRIM26 is a critical host factor for HCV replication and contributes to host tropism, Liang, Yisha, Zhang, Guigen, Li, Qiheng, Han, Lin, Hu, Xiaoyou, Guo, Yu, Tao, Wanyin, Zhao, Xiaomin, Guo, Mingzhe, Gan, Tianyu, Tong, Yimin, Xu, Yongfen, Zhou, Zhuo, Ding, Qiang, Wei, Wensheng, Zhong, Jin, 2021
  • Glycometabolism regulates hepatitis C virus release, Tao Yu, Qiankun Yang, Fangling Tian, Haishuang Chang, Zhenzheng Hu, Bowen Yu, Lin Han, Yifan Xing, Yaming Jiu, Yongning He, Jin Zhong, 2021
  • Corrigendum to 'DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication' Virology 435 (2013) 385–394, Xi Kang, Xi Chen, Ying He, Deyin Guo, Lin Guo, Jin Zhong, HongBing Shu, 2021
  • UNC93B1 curbs cytosolic DNA signaling by promoting STING degradation, He, Zhenliang, Ye, Sichao, Xing, Yifan, Jiu, Yaming, Zhong, Jin, 2021
  • Hepatitis C virus genotype 4: A poorly characterized endemic genotype, Leumi, Steve, El Kassas, Mohamed, Zhong, Jin, 2021
  • A novel cell culture system modeling the SARS-CoV-2 life cycle, Ju, Xiaohui, Zhu, Yunkai, Wang, Yuyan, Li, Jingrui, Zhang, Jiaxing, Gong, Mingli, Ren, Wenlin, Li, Sai, Zhong, Jin, Zhang, Linqi, Zhang, Qiangfeng Cliff, Zhang, Rong, Ding, Qiang, 2021
  • Development of a New Reverse Genetics System for Ebola Virus, Tianyu Gan, Dihan Zhou, Yi Huang, Shuqi Xiao, Ziyue Ma, Xiaoyou Hu, Yimin Tong, Huimin Yan, Jin Zhong, 2021
  • Cryo-EM structures of Lassa and Machupo virus polymerases complexed with cognate regulatory Z proteins identify targets for antivirals, Xu, Xin, Peng, Ruchao, Peng, Qi, Wang, Min, Xu, Ying, Liu, Sheng, Tian, Xiaolin, Deng, Haiteng, Tong, Yimin, Hu, Xiaoyou, Zhong, Jin, Wang, Peiyi, Qi, Jianxun, Gao, George F, Shi, Yi, 2021
  • DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication (vol 435, pg 385, 2013), Kang, Xi, Chen, Xi, He, Ying, Guo, Deyin, Guo, Lin, Zhong, Jin, Shu, HongBing, 2021
  • Anti-flavivirus activity of polyoxometalate, Qi, Yue, Han, Lin, Qi, Yanfei, Jin, Xia, Zhang, Bo, Niu, Junqi, Zhong, Jin, Xu, Yongfen, 2020
  • 关于新型冠状病毒命名的思考与建议, 张冬梅, 姜世勃, 石正丽, 谭文杰, 卢洪洲, 曹彬, 张文宏, 刘叔文, 钟劲, 肖庚富, 谢幼华, 邓凯, 赵金存, 杨子峰, 宋敬东, 陆路, 黄竞荷, 应天雷, 王乔, 施莽, 徐建青, 安静, 鲁凤民, 高福, 舒跃龙, 郭德银, 2020
  • Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum Inhibitor against Flavivirus Infections, Yang, Jingjing, Xu, Yongfen, Yan, Yunzheng, Li, Wei, Zhao, Lei, Dai, Qingsong, Li, Yuexiang, Li, Song, Zhong, Jin, Cao, Ruiyuan, Zhong, Wu, 2020
  • IL-1β enhances anti-viral effect of IFN-α on HCV replication by negatively modulating ERK2 activation, Zhong Jing, 2020
  • 2020年度诺奖解读, 谢磊, 钟劲, 2020
  • A Nanoparticle-Based Hepatitis C Virus Vaccine With Enhanced Potency, Yan, Yu, Wang, Xuesong, Lou, Peilan, Hu, Zhenzheng, Qu, Panke, Li, Dapeng, Li, Qingchao, Xu, Yongfen, Niu, Junqi, He, Yongning, Zhong, Jin, Zhong, Huang, 2020
  • 分子生物学技术推进丙型肝炎病毒的发现和研究——2020年诺贝尔生理学或医学奖解读, 李庆超, 钟劲, 2020
  • An Alternative Splicing of Tupaia STING Modulated Anti-RNA Virus Responses by Targeting MDA5-LGP2 and IRF3, Xu, Ling, Yu, Dandan, Peng, Li, Wu, Yong, Fan, Yu, Gu, Tianle, Yao, YuLin, Zhong, Jin, Chen, Xinwen, Yao, YongGang, 2020
  • Discovery and research of hepatitis C virus-Thoughts from the 2020 Nobel Prize in Physiology or Medicine, Xu, Yongfen, Long, Gang, Zhong, Jin, 2020
  • Tupaia MAVS Is a Dual Target during Hepatitis C Virus Infection for Innate Immune Evasion and Viral Replication via NF-kappa B, Xu, Ling, Yu, Dandan, Yao, YuLin, Gu, Tianle, Zheng, Xiao, Wu, Yong, Luo, RongHua, Zheng, YongTang, Zhong, Jin, Yao, YongGang, 2020
  • A novel approach to display structural proteins of HCV quasispecies in patients reveals a key role of E2 HVR1 in viral evolution, Zhong Jing, 2020
  • 丙型肝炎病毒的发现及研究——从2020年度诺贝尔生理学或医学奖谈起, 徐咏芬, 龙钢, 钟劲, 2020
  • Multifaceted Functions of Host Cell Caveolae/Caveolin-1 in Virus Infections, Xing, Yifan, Wen, Zeyu, Gao, Wei,
Hcv Hepatitis C Virology Immunology Antiviral Drug Screening Virus-Host Interaction Cell Culture Model Molecular Mechanism Therapeutics

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.